Suchergebnisse - "Cook, Gordon"

PubPharm (108)

1

Daratumumab, Cyclophosphamide, Bortezomib, Lenalidomide, and Dexamethasone as Induction and Extended Consolidation Improves Outcome in Ultra-High-Risk Multiple Myeloma

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Kaiser, M. | Hall, A. | Walker, K. | +17

2

Cytokine receptor IL27RA is an NF-κB-responsive gene involved in CD38 upregulation in multiple myeloma

enthalten in: Blood advances | 2023

von Brownlie, R. | Kennedy, R. | Wilson, E. | +18

3

SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease

enthalten in: Nature medicine | 2023

von Barnes, E. | Goodyear, C. | Willicombe, M. | +146

4

Prevention and management of adverse events during treatment with bispecific antibodies and CAR T cells in multiple myeloma : a consensus report of the European Myeloma Network

enthalten in: The Lancet. Oncology | 2023

von Ludwig, H. | Terpos, E. | van de Donk, N. | +26

5

Immune responses to COVID-19 booster vaccinations in intensively anti-CD38 antibody treated patients with ultra-high-risk multiple myeloma : results from the Myeloma UK (MUK) nine OPTIMUM trial

enthalten in: British journal of haematology | 2023

von Faustini, S. | Hall, A. | Brown, S. | +12

6

Daratumumab, bortezomib and dexamethasone at first relapse for patients with multiple myeloma : A real-world multicentre UK retrospective analysis

enthalten in: British journal of haematology | 2023

von McMillan, A. | Basu, S. | Karunanithi, K. | +22

7

The addition of vorinostat to lenalidomide maintenance for patients with newly diagnosed multiple myeloma of all ages : results from 'Myeloma XI', a multicentre, open-label, randomised, phase III trial

enthalten in: British journal of haematology | 2023

von Jenner, M. | Pawlyn, C. | Davies, F. | +16

8

Optimizing the value of lenalidomide maintenance by extended genetic profiling : an analysis of 556 patients in the Myeloma XI trial

enthalten in: Blood | 2023

von Panopoulou, A. | Cairns, D. | Holroyd, A. | +13

CommentIn: Blood. 2023 Apr 6;141(14):1649-1650. - PMID 37022733

9

Rates of Influenza and Pneumococcal Vaccination and Correlation With Survival in Multiple Myeloma Patients

enthalten in: Clinical lymphoma, myeloma & leukemia | 2023

von Thompson, M. | Boccadoro, M. | Leleu, X. | +26

10

Delayed diagnosis resulting in increased disease burden in multiple myeloma : the legacy of the COVID-19 pandemic

enthalten in: Blood cancer journal | 2023

von Carmichael, J. | Seymour, F. | McIlroy, G. | +9

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[11]